Awesome FinTech
Get access
feedback
Samsara Biocapital, LLC provides investment advisory services.
Exits 30
Investments 79
Lead Investments 14
Investments
Series B - ACELYRIN
ACELYRIN250M USD
Series A - Tentarix Biotherapeutics
Tentarix Biotherapeutics50M USD
Post-IPO Equity - Science 37
Science 37200M USD
Series B - Exo Therapeutics
Exo Therapeutics78M USD
Series B - Obsidian Therapeutics
Obsidian Therapeutics115M USD
Series B - Alamar Biosciences
Alamar Biosciences80M USD
Series B - Attralus
Attralus116M USD
Series B - Neurogastrx
Neurogastrx60M USD
Post-IPO Equity - Tango Therapeutics
Tango Therapeutics186M USD
Venture Round - Pepgen
Pepgen113M USD
Funds
Mar 26th 18
Fund I 310M USD
Verticals
BioTech
Pharmaceuticals
FinTech
Logistics
Manufacturing
Digital Health
Health & Hospital Services
Health IT
Investors
Access all investors here
Access more information on Samsara BioCapital
Join now
Categories